What does CUSIP 75629V904 represent in this 13F holders report?

CUSIP 75629V904 is the security identifier for 75629V904 - RECURSION PHARMACEUTICALS IN - CALL used to aggregate holder disclosures.

How many institutions held 75629V904 - RECURSION PHARMACEUTICALS IN - CALL in Q2 2024?

No institutional holders were reported for 75629V904 - RECURSION PHARMACEUTICALS IN - CALL in Q2 2024; review adjacent reporting periods for trend context.

RECURSION PHARMACEUTICALS IN - CALL

CUSIP: 75629V904

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class: Equity / CALL
Price per share: $7.50
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 75629V904?
CUSIP 75629V904 identifies 75629V904 - RECURSION PHARMACEUTICALS IN - CALL in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2024
Previous quarter: Q1 2024

Recent filing periods for CUSIP 75629V904:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

RECURSION PHARMACEUTICALS IN - CALL

Q2 2024 13F Holders as of 30 Jun 2024

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of RECURSION PHARMACEUTICALS IN - CALL as of Q2 2024.